Sarepta Therapeutics, Inc. (SRPT)

18.50 +1.47 (+8.63%) USD  |  NASDAQ  |  Feb 06, 16:00
18.43 -0.07 (-0.38%) Pre-Market: 08:49
More

Sarepta Therapeutics Total Operating Expenses (% of Quarterly Revenues)

Total Operating Expenses (% of Quarterly Revenues) Chart

View Total Operating Expenses (% of Quarterly Revenues) for SRPT.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Total Operating Expenses (% of Quarterly Revenues) Chart
Start Trial

Historical Data

View Historical Data
Start Trial

Total Operating Expenses (% of Quarterly Revenues) Range, Past 5 Years

View Total Operating Expenses (% of Quarterly Revenues) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Total Operating Expenses (% of Quarterly Revenues) Benchmarks

View Total Operating Expenses (% of Quarterly Revenues) Benchmarks
Start Trial
Arrowhead Pharmaceuticals, Inc. Upgrade
Merck & Co., Inc. Upgrade
Pfizer Inc. Upgrade
Keros Therapeutics, Inc. Upgrade
Alnylam Pharmaceuticals, Inc. Upgrade